ArticleBMJ oncology2026

Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.

Yuxin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.